SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-18-038592
Filing Date
2018-07-17
Accepted
2018-07-17 08:00:32
Documents
2
Period of Report
2018-08-22
Effectiveness Date
2018-07-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tv498367_def14a.htm DEF 14A 154595
2 GRAPHIC logo.jpg GRAPHIC 11186
  Complete submission text file 0001144204-18-038592.txt   171258
Mailing Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE, SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201-464-2677
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

IRS No.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36602 | Film No.: 18955524
SIC: 2834 Pharmaceutical Preparations